Microarrays and cancer diagnosis

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Cancer is characterized by disrupted cellular differentiation and proliferation, akin to a developmental disorder.
• Cancer cells possess biomolecules essential for survival, proliferation, differentiation, cell death, and function.
• Microarray analysis, a genomic tool, has advanced the understanding of malignancy.

Purpose of the Study:

• To explore the clinical utility of microarray analysis in human cancer diagnosis and classification.
• To highlight the role of nucleotide-based technologies in defining the molecular basis of cancer.

Main Methods:

• Review of existing literature on microarray studies in cancer.
• Analysis of nucleotide-based microarray technologies for cancer research.

Main Results:

• Microarray analysis has demonstrated significant potential in cancer diagnosis.
• Microarray data can aid in cancer risk stratification and patient management.
• Recent advancements in microarray technology enhance the definition of malignancy's molecular basis.

Conclusions:

• Microarray analysis holds clinical utility for cancer diagnosis, risk stratification, and patient management.
• Further adoption of microarray analysis is recommended for improved cancer care.
• Nucleotide-based microarrays are crucial for understanding cancer's molecular underpinnings.